Exploring the binding mode of donepezil with calf thymus DNA using spectroscopic and molecular docking methods

Luminescence. 2021 Feb;36(1):35-44. doi: 10.1002/bio.3911. Epub 2020 Jul 18.

Abstract

Donepezil (DNP) is one of approved drugs to treat Alzheimer's disease (AD). However, the potential effect of DNP on DNA is still unclear. Therefore, the interaction of DNP with calf thymus DNA (DNA) was studied in vitro using spectroscopic and molecular docking methods. Steady-state and transient fluorescence experiments showed that there was a clear binding interaction between DNP and DNA, resulting from DNP fluorescence being quenched using DNA. DNP and DNA have one binding site between them, and the binding constant (Kb ) was 0.78 × 104 L·mol-1 at 298 K. In this binding process, hydrophobic force was the main interaction force, because enthalpy change (ΔH) and entropy change (ΔS) of DNP-DNA were 67.92 kJ·mol-1 and 302.96 J·mol-1 ·K-1 , respectively. DNP bound to DNA in a groove-binding mode, which was verified using a competition displacement study and other typical spectroscopic methods. Fourier transform infrared (FTIR) spectrum results showed that DNP interacted with guanine (G) and cytosine (C) bases of DNA. The molecular docking results further supported the results of spectroscopic experiments, and suggested that both Pi-Sigma force and Pi-Alkyl force were the major hydrophobic force functioning between DNP and DNA.

Keywords: calf thymus DNA; donepezil; interaction; molecular docking; spectroscopy.

MeSH terms

  • Binding Sites
  • Circular Dichroism
  • DNA*
  • Donepezil
  • Molecular Docking Simulation
  • Spectrometry, Fluorescence
  • Spectrophotometry, Ultraviolet
  • Thermodynamics

Substances

  • Donepezil
  • DNA
  • calf thymus DNA